Literature DB >> 25541150

Biological properties of ligand-dependent activation of the MET receptor kinase in acute myeloid leukemia.

S F McGee1, S M Kornblau2, Y Qiu2, A T Look3, N Zhang4, S-Y Yoo4, K R Coombes5, A Kentsis6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25541150      PMCID： PMC4638218          DOI： 10.1038/leu.2014.348

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  19 in total

1.  Survivin is highly expressed in CD34(+)38(-) leukemic stem/progenitor cells and predicts poor clinical outcomes in AML.

Authors:  Bing Z Carter; Yihua Qiu; Xuelin Huang; Lixia Diao; Nianxiang Zhang; Kevin R Coombes; Duncan H Mak; Marina Konopleva; Jorge Cortes; Hagop M Kantarjian; Gordon B Mills; Michael Andreeff; Steven M Kornblau
Journal:  Blood       Date:  2012-05-29       Impact factor: 22.113

2.  MET receptor sequence variants R970C and T992I lack transforming capacity.

Authors:  Jeffrey W Tyner; Luke B Fletcher; Ellen Q Wang; Wayne F Yang; Michael L Rutenberg-Schoenberg; Carol Beadling; Motomi Mori; Michael C Heinrich; Michael W Deininger; Brian J Druker; Marc M Loriaux
Journal:  Cancer Res       Date:  2010-08-01       Impact factor: 12.701

Review 3.  New agents for acute myeloid leukemia: is it time for targeted therapies?

Authors:  Felicetto Ferrara
Journal:  Expert Opin Investig Drugs       Date:  2012-01-05       Impact factor: 6.206

4.  Abnormal expression of FLI1 protein is an adverse prognostic factor in acute myeloid leukemia.

Authors:  Steven M Kornblau; Yi Hua Qiu; Nianxiang Zhang; Neera Singh; Stefan Faderl; Alessandra Ferrajoli; Heather York; Amina A Qutub; Kevin R Coombes; Dennis K Watson
Journal:  Blood       Date:  2011-09-13       Impact factor: 22.113

5.  Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors.

Authors:  Timothy R Wilson; Jane Fridlyand; Yibing Yan; Elicia Penuel; Luciana Burton; Emily Chan; Jing Peng; Eva Lin; Yulei Wang; Jeff Sosman; Antoni Ribas; Jiang Li; John Moffat; Daniel P Sutherlin; Hartmut Koeppen; Mark Merchant; Richard Neve; Jeff Settleman
Journal:  Nature       Date:  2012-07-26       Impact factor: 49.962

6.  Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia.

Authors:  Timothy J Ley; Christopher Miller; Li Ding; Benjamin J Raphael; Andrew J Mungall; A Gordon Robertson; Katherine Hoadley; Timothy J Triche; Peter W Laird; Jack D Baty; Lucinda L Fulton; Robert Fulton; Sharon E Heath; Joelle Kalicki-Veizer; Cyriac Kandoth; Jeffery M Klco; Daniel C Koboldt; Krishna-Latha Kanchi; Shashikant Kulkarni; Tamara L Lamprecht; David E Larson; Ling Lin; Charles Lu; Michael D McLellan; Joshua F McMichael; Jacqueline Payton; Heather Schmidt; David H Spencer; Michael H Tomasson; John W Wallis; Lukas D Wartman; Mark A Watson; John Welch; Michael C Wendl; Adrian Ally; Miruna Balasundaram; Inanc Birol; Yaron Butterfield; Readman Chiu; Andy Chu; Eric Chuah; Hye-Jung Chun; Richard Corbett; Noreen Dhalla; Ranabir Guin; An He; Carrie Hirst; Martin Hirst; Robert A Holt; Steven Jones; Aly Karsan; Darlene Lee; Haiyan I Li; Marco A Marra; Michael Mayo; Richard A Moore; Karen Mungall; Jeremy Parker; Erin Pleasance; Patrick Plettner; Jacquie Schein; Dominik Stoll; Lucas Swanson; Angela Tam; Nina Thiessen; Richard Varhol; Natasja Wye; Yongjun Zhao; Stacey Gabriel; Gad Getz; Carrie Sougnez; Lihua Zou; Mark D M Leiserson; Fabio Vandin; Hsin-Ta Wu; Frederick Applebaum; Stephen B Baylin; Rehan Akbani; Bradley M Broom; Ken Chen; Thomas C Motter; Khanh Nguyen; John N Weinstein; Nianziang Zhang; Martin L Ferguson; Christopher Adams; Aaron Black; Jay Bowen; Julie Gastier-Foster; Thomas Grossman; Tara Lichtenberg; Lisa Wise; Tanja Davidsen; John A Demchok; Kenna R Mills Shaw; Margi Sheth; Heidi J Sofia; Liming Yang; James R Downing; Greg Eley
Journal:  N Engl J Med       Date:  2013-05-01       Impact factor: 91.245

7.  Structural basis of hepatocyte growth factor/scatter factor and MET signalling.

Authors:  Ermanno Gherardi; Sara Sandin; Maxim V Petoukhov; John Finch; Mark E Youles; Lars-Göran Ofverstedt; Ricardo N Miguel; Tom L Blundell; George F Vande Woude; Ulf Skoglund; Dmitri I Svergun
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-06       Impact factor: 11.205

8.  Autocrine activation of the MET receptor tyrosine kinase in acute myeloid leukemia.

Authors:  Alex Kentsis; Casie Reed; Kim L Rice; Takaomi Sanda; Scott J Rodig; Eleni Tholouli; Amanda Christie; Peter J M Valk; Ruud Delwel; Vu Ngo; Jeffery L Kutok; Suzanne E Dahlberg; Lisa A Moreau; Richard J Byers; James G Christensen; George Vande Woude; Jonathan D Licht; Andrew L Kung; Louis M Staudt; A Thomas Look
Journal:  Nat Med       Date:  2012-07       Impact factor: 53.440

9.  Heparin induces dimerization and confers proliferative activity onto the hepatocyte growth factor antagonists NK1 and NK2.

Authors:  R H Schwall; L Y Chang; P J Godowski; D W Kahn; K J Hillan; K D Bauer; T F Zioncheck
Journal:  J Cell Biol       Date:  1996-05       Impact factor: 10.539

10.  An uncleavable form of pro-scatter factor suppresses tumor growth and dissemination in mice.

Authors:  Massimiliano Mazzone; Cristina Basilico; Silvia Cavassa; Selma Pennacchietti; Mauro Risio; Luigi Naldini; Paolo M Comoglio; Paolo Michieli
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808
View more
  3 in total

1.  Merestinib blocks Mnk kinase activity in acute myeloid leukemia progenitors and exhibits antileukemic effects in vitro and in vivo.

Authors:  Ewa M Kosciuczuk; Diana Saleiro; Barbara Kroczynska; Elspeth M Beauchamp; Frank Eckerdt; Gavin T Blyth; Sameem M Abedin; Francis J Giles; Jessica K Altman; Leonidas C Platanias
Journal:  Blood       Date:  2016-06-15       Impact factor: 22.113

Review 2.  Overcoming resistance to targeted therapy using MET inhibitors in solid cancers: evidence from preclinical and clinical studies.

Authors:  Nehad M Ayoub; Dalia R Ibrahim; Amer E Alkhalifa
Journal:  Med Oncol       Date:  2021-10-19       Impact factor: 3.064

3.  Gene mutation profile and risk stratification in AML1‑ETO‑positive acute myeloid leukemia based on next‑generation sequencing.

Authors:  Guopan Yu; Changxin Yin; Fuqun Wu; Ling Jiang; Zhongxin Zheng; Dan Xu; Jiaheng Zhou; Xuejie Jiang; Qifa Liu; Fanyi Meng
Journal:  Oncol Rep       Date:  2019-10-15       Impact factor: 3.906
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.